News & Views
- Posted By: TreehillPartners
- In: Drug Development, Leadership & Restructuring, Strategy & Corporate Development
In this episode, BioSpace’s Head of Insights Lori Ellis, Miguel Forte and Ali Pashazadeh, Treehill Partners CEO, speculate on the impending Trump administration, discuss current challenges faced by CEOs, and weigh investment in GLP-1s...
- Posted By: TreehillPartners
- In: Dealmaking, Drug Development, Strategy & Corporate Development
The pharmaceutical industry is at the commercial interface between innovation, patients, caregivers and payers. With U.S. elections now behind...
- Posted By: TreehillPartners
- In: Drug Development, Financing & Capital Markets, Strategy & Corporate Development
Read the full interview of Ali Pashazadeh, Treehill Partners CEO at Genetic Engineering & Biotechnology News (GEN) - a renown publication where GEN's unique news and technology focus covers the entire bioproduct life cycle...
- Posted By: TreehillPartners
- In: Drug Development
Read Ali Pashazadeh's viewpoints on pricing uncertainty, dealmaking, and industry checks and balances along the thoughts of other industry KOLs...